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Comparison of how ambient PMc and PM2.5 influence the
inflammatory potential
Matthew D. Ferguson1, Chris Migliaccio1, and Tony Ward1,*
1 University of Montana, Center for Environmental Health Sciences, Missoula, Montana.
Abstract
Airborne particulate matter (PM) is one of six criteria air pollutants currently regulated by the U.S.
Environmental Protection Agency (EPA), with existing ambient standards for PM2.5 and PM10.
Currently there are no health-based regulations for the size fraction between 2.5 and 10 μm,
commonly known as the coarse fraction (PMc). The present study investigates current gaps in
knowledge for PMc including exposure toxicity and PM ratios (PMc:PM2.5) in PM10. Throughout
the world, all three PM size fractions have been shown to be associated with adverse impacts.
Recent studies have shown that PMc can be more detrimental to susceptible populations when
directly compared to PM2.5, and that the PMc fraction in PM10 can account for the majority of the
inflammatory response from PM10 exposure.
In our studies we utilized a bone marrow-derived mouse macrophage in vitro system to compare
the inflammatory potential of PMc, PM2.5, and mixtures of the two. The result was a linear
increase in interleukin(IL) −1β with increasing levels of exposure to winter and summer PMc, as
compared to PM2.5, which exhibited logarithmic growth. Also, exposure to PM10 as a function of
PM2.5 and PMc mass ratios showed that IL-1β and TNF-α levels increased synergistically with a
greater burden of PMc. Endotoxin content in the PM did not correlate with these results,
suggesting that other activators in PMc are likely responsible for activating the NF-κB pathway
and the inflammasome.
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Introduction
Airborne particulate matter (PM) is a known causative agent in inducing or exacerbating a
variety of respiratory and cardiovascular diseases (Pelucchi et al. 2009, Brook et al. 2010,
Dvonch et al. 2009, Samet et al. 2009, Weinmayr et al. 2010, Zanobetti et al. 2010, Xu et al.
2011). PM is also one of six criteria air pollutants currently regulated by the United States
Environmental Protection Agency (EPA), with existing ambient standards for both PM2.5
and PM10 (i.e. particulate matter (PM) with mean aerodynamic diameters <2.5 and <10
micrometers (μm), respectively). Currently there are no health-based regulations for the size
fraction between 2.5 and 10 μm, commonly known as the coarse fraction (PMc). Compared
to ambient PM2.5 and PM10 (which are routinely measured across the US), much less is
known about PMc seasonal concentrations and health effects. In multiple research studies
conducted throughout the world, all three PM size fractions have been shown to be
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associated with adverse impacts (Gilmour et al. 2007, Gordian et al. 1996, Host et al. 2008,
Mar et al. 2004, Monn and Becker 1999, Ostro et al. 2000, Pelucchi et al. 2009 2007).
PMc has been shown to cause a more significant pulmonary inflammatory response than
PM2.5 in animal models (Tong et al. 2010, Wegesser and Last 2009), as well as increased
inflammatory potential in multiple respiratory cell lines (Gualtieri et al. 2010). Becker et al.
(Becker et al. 2005) reported that compared to PM2.5, PMc induced higher levels of the
inflammation markers IL-6 and Cox-2 mRNA in alveolar macrophages, and higher levels of
IL-8 and Cox-2 mRNA in normal human bronchial epithelial cells. These studies suggest
that the coarse fraction in PM10 accounts for 90-95% of the resulting inflammatory response
(Becker et al. 2005). These findings may be explained by the biological composition of
PMc, as the coarse fraction can contain up to 10 times the amount of biological content
compared to PM2.5 (Heinrich et al. 2003). This biological content includes pathogen
associated molecular patterns (PAMPS), such as endotoxin, which prime the activation of
the inflammasome (Tschopp and Schroder 2010, Yazdi et al. 2010). The inflammasome is a
protein complex that once formed can stimulate maturation of pro-IL-1β to its active form,
IL-1β. However, a pool of pro-IL-1β will need to be maintained allowing the inflammasome
to continue its function. Endotoxin has also been shown to trigger the NF-κB pathway and
downstream pro-IL-1β production via TLR4 (Schins et al. , Bauernfeind et al. 2009),
suggesting that ambient PM-induced adverse health outcomes may be heavily influenced by
the PMc fraction.
A tenet of toxicology is that exposure to environmental toxicants will likely occur as a
mixture, with the outcome being a function of the joint effects of this mixture. A measure of
how a mixture can maintain, lower, or increase a toxic outcome is termed additivity. For
example, laboratory studies exposing humans to both carbon black particles and O3 resulted
in greater lung inflammation and suppression of alveolar macrophage phagocytosis than
would be predicted using the sum of both toxicities alone (Jakab and Hemenway 1994).
These results suggest a synergism in the lung, or a greater than additive toxicity between
carbon black and O3.
Toxic consequences from mixture exposures have two other outcomes other than synergism.
An inverse relationship to synergism may also be observed where antagonism takes place,
i.e. a decrease in toxic potential, less than additive. Finally, when two toxicants are
introduced in a mixture and if one toxic does not affect the other, and visa versa, the mixture
effect is termed additive.
Although multiple studies have been conducted linking either PM2.5 or PM10 to respiratory
disease throughout the world, little research has been conducted investigating the role of
these two PM size fractions in mixture, specifically how the PMc size class influences
overall PM10 inducible toxicity. In the real world, exposure to PM10 occurs as a function of
PMc and PM2.5 mass ratios. These mixtures can change as a function of geography,
temporality, and seasonal conditions (e.g. wildfires, winter inversions, etc.). In this
manuscript, we describe the results of studies that evaluated the additive effect of ambient
PM2.5 and PMc mixtures. Following the harvesting of ambient PM using a particle
concentrator, an in vitro model of inflammation was used to determine the contributions of
PMc within a mixture. The overall goal of these studies was to not only investigate the
inflammation potential of PMc compared to PM2.5, but also to elucidate the relative
contributions of these two size fractions to observed health effects.
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Methods
Collection of Ambient Particles
Seasonal PM was collected in Missoula, Montana, a valley airshed located in west-central
Montana. With a population of 70 000, Missoula is the 2nd largest city in the state of
Montana. Particles were collected using a versatile aerosol concentration enrichment system
particle concentrator (VACES-PC, University of Southern California). The concentrator has
three parallel sampling lines that simultaneously collect PM2.5 and PMc, respectively, at a
set flow rate of 110 L/min (Kim et al. 2001a, Kim et al. 2001b). Following each sample run,
the product (i.e. particles in ultrapure water) was stored at −20° and later lyophilized to
concentrate particles for further studies. The particle concentrator is housed on the roof of a
four story building on the University of Montana campus. Particles were harvested during
the winter (February 2012), spring (May 2012), and summer months (July and August
2012). These collection periods yielded from 100 μg to about 1 mg of each PM type,
depending on conditions.
Ambient PM Levels in Missoula
Although PMc sampling is not currently conducted in Missoula, continuous PM2.5 and PM10
are routinely measured as part of Missoula’s EPA compliance monitoring program. This
program uses these continuous PM data to calculate 24-hour ambient PM averages, which
are then reported. Using these continuous PM2.5 and PM10 data (collected with a MetOne
BAM at the Missoula Boyd Park site), we were able to calculate, by difference, the seasonal
ambient PMc mass concentrations during 2012 ([PM10] – [PM2.5] = [PMc]). We also
calculated the 24-hour average mass concentrations on days when PM was collected with
the particle concentrator and used in this work. The unique seasonal patterns in Missoula,
MT are accounted for in this study, as high latitudes and high elevations stimulate longer
cold seasons. For the purpose of this manuscript, winter months are categorized as the
months of November, December, January, and February; spring are the months of March,
April, and May; summer months are the months of June, July, and August; and autumn is
September and October.
Mice and Bone Marrow-Derived Macrophages
A major component of respiratory immunity is the pulmonary macrophage, which plays a
key role in the regulation of inflammation as well as subsequent adaptive responses.
Pulmonary macrophages are perpetual residents of the lung and act as sentinels or first
responders for particle uptake. These macrophages have the necessary receptors for particle
uptake/phagocytosis (Hirayama et al. 2011, Geiser 2010, Goodridge et al. 2012, Underhill
and Goodridge 2012). Our laboratory has published multiple in vivo particulate exposure
studies using the Balb/c mouse model (Migliaccio et al. 2005, Migliaccio et al. 2008, Lacher
et al. 2010, Migliaccio et al. 2013). In addition to these studies, our laboratory has also
utilized an in vitro macrophage system using bone marrow-derived macrophages (BMdMs)
to evaluate the effects of particles on cell functions (Migliaccio et al. 2005, Migliaccio et al.
2008). Therefore, by exposing mouse BMdMs to PM, an inflammatory response can be
measured.
A variety of studies have described the key role of the pulmonary macrophage in particle
clearance (Geiser 2010), and its link between the innate and adaptive immune systems
(Gordon 2003, Mosser 2003). Bone marrow-derived macrophages utilized in this study to
evaluate the inflammatory response of relevant doses of different PM fractions (PM2.5,
PM10, and PMc). Methods for BMdM cultures are previously described (Pfau et al. 2004,
Migliaccio et al. 2008). Briefly, hind legs of euthanized Balb/c mice (Jackson Laboratory,
Bar Harbor, ME, USA) were flushed with media (RPMI 1640 with 10% FBS) to release the
Ferguson et al. Page 3
marrow. After overnight stromal elimination, cells were stimulated with M-CSF for an
additional 7-10 days of culturing. On day 10, cells were aliquoted (105 cells/well) in 96-well
plates for culturing with particles. All animal procedures were approved by the University of
Montana Institutional Animal Care and Use Committee (Missoula, MT, USA). Method of
euthanasia was by lethal dose of sodium pentobarbital via interperitoneal injection.
PMc vs. PM2.5 Comparison Studies
During the summer (July, 2011) and winter (February, 2012) months, PM2.5 and PMc, were
simultaneously harvested in Missoula using our VACES-PC. Stock solutions of PM were
made by diluting pre-determined masses of PM into a small volume of PBS (< 0.5 mL)
followed by sonication. The volume of PBS necessary is dependent on the amount of PM
harvested. Cells were incubated with particles for 1 hour (mixing) in 1.5 mL eppendorf
tubes, then aliquoted to 96-well plates and cultured overnight. Final cultures contained 150
μL per well of media, with each condition in triplicate exposures at 100 000 cells/well. A
media negative control was also used that contained no particles. Particle exposure levels
included varying masses of PM2.5 or PMc at 5 μg, 20 μg, and 40 μg/well. Collection of
supernatants occurred after 24 hours.
PM Mixture Studies
PM2.5 and PMc used in the mixture exposures were harvested during May 2012. BMdMs
were exposed in a similar fashion as the comparison studies described above, but at one
level of exposure at 20 μg/well. To represent the varying conditions of PM10, 20 μg
mixtures of PM2.5 and PMc varied from 0%, 20%, 40%, 60%, 80%, and 100% PMc by
mass. For these studies, 20 μg was used, as it was the lowest mass of exposure that induced
the most significant differences between PM size and season with both IL-1β and TNF-α. In
similar studies using in vivo models, particulate exposures ranged from 5-50 μg of particles
per instillation (Porter et al. 2013, Stoeger et al. 2006). Considering that there are roughly
200-300 thousand alveolar macrophages in the mouse lung, if 50 μg is distributed evenly,
each cell will theoretically receive approximately 0.17-0.25 ng of particles. In our model
using 20 μg and 100 000 cells, if particles were distributed evenly, each cell would receive
roughly 0.2 ng of particles. Therefore, the levels of particulates used in this research are
representative of in vivo studies.
Collection of supernatants occurred after 24 hours of incubation. The resulting inflammatory
cytokine levels were used to determine the additivity potential of the mixtures. To ensure
that these particles were undergoing phagocytosis, bright field illumination microscopy of
BMdMs following 24-hours of exposure to PM10, was performed (Nikon Eclipse E800,
Tokyo, Japan; Nuance Multispectral Imaging System, Hopkinton, Massachusetts).
Endotoxin Analysis
Levels of endotoxin were evaluated using methods adapted by Thorne (Thorne 2000).
Briefly, the harvested PM samples were analyzed for endotoxin levels using a kinetic
chromogenic Limulus amebocyte lysate (LAL) assay (Charles River Endosafe® -
Endochrome-K ™, Charles River Laboratories, Charleston, SC, USA), where a 12-point
standard curve ranged from 50 to 0.005 EU/ml. The absorbance was measured at 405 nm
every 30 seconds for 90 minutes.
Mixture Effect Calculation
Additivity was modeled using equation 1, a modified version of the toxic unit model
(PapeLindstrom and Lydy 1997). Modification was necessary, as endpoints were not based
on concentration/dose response thresholds, but were based on the resulting levels of the
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expressed cytokines from 20 μg of PM exposure. Where additivity is > 1, = 1, or < 1 the
effect of the mixture is deemed synergistic, additive, or antagonistic, respectively. The
fraction of PM2.5 or PMc in PM10 is represented with f and can range anywhere from 0 to 1.
For example, if PM10 contained 25% PM2.5 and 75% PMc, f would equal 0.25 and 0.75,
respectively.
(1)
As the ratios of PM2.5 and PMc change within total PM10, a departure from an effect level of
1 explains whether a larger burden of one PM size fraction is either affecting a synergistic
(additivity >1) or an antagonistic (additivity <1) effect. One other alternative is that the
mixture will not cause a departure from 1, and that the increased presence of one or another
PM type will result in an additive response.
Cytokine and Statistical Analysis
Collection of pro-inflammatory cytokines was completed following the 24-hour exposure.
The collected media/supernatant was then stored at −20° C prior to analysis via enzyme-
linked immunosorbent assay (ELISA; R&D Systems, Minneapolis, MN, USA). Each well’s
concentration was measured in duplicate. Levels of IL-1β and TNF-α released from BMdMs
were then plotted using Prism, version 5.0a. Student t-tests were also performed in Prism to
determine significant differences between two PM types within each mass of exposure (5
μg, 20 μg, and 40 μg).
Results
Ambient air data in Missoula, MT
Table 1 summarizes the average concentrations of PM2.5, PMc, and PM10 measured
throughout 2012, illustrating that PMc is not only a substantial component of PM10
throughout the year, but also is present in elevated concentrations (compared to PM2.5)
throughout all four seasons in this northern Rocky Mountain airshed. The data presented in
Table 1 indicate that ambient PM concentrations (PM2.5, PMc, and PM10) vary as a function
of season. Throughout the year, seasonal PMc concentrations measured in Missoula, MT
were consistently higher than PM2.5, even in winter when there were more combustion-
related particles in the Missoula airshed due to residential wood stove use (Ward and Lange
2010). Unlike PM2.5, PMc average concentrations were fairly consistent through winter and
spring (9.3-9.6 μg/m3), with a marked increase in PMc from summer to fall. PM2.5
concentrations in fall were at least twice as high as all other seasons.
PM concentrations on days that ambient particles were harvested for the controlled
laboratory exposure studies (PMc vs. PM2.5 comparison and mixture studies) are presented
in Table 2. During the days that PM was harvested during the winter months, the PMc
concentrations were more than twice as high compared to the winter-long average presented
in Table 1, though PM2.5 concentrations were similar. The authors are unsure why PMc was
elevated on these sample days. When comparing PMc concentrations measured during
harvest days compared to overall summer averages, concentrations are comparable. The
same is true for collected Spring PM. Also during these collection days (Table 2), PM2.5
concentrations were comparable to the winter, spring, and summer averages presented in
Table 1.
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PM non-mixture exposures, in vitro
In side-by-side controlled exposures within the laboratory, winter PMc induced the highest
levels of IL-1β and TNF-α at all three doses (Figure 1), supporting our hypothesis that PMc
is more biologically active compared to PM2.5. Summer PMc was the second most bioactive
PM, followed by summer PM2.5 and winter PM2.5. In each season (winter and summer), the
most bioactive size fraction of PM was PMc, with winter PMc inducing more than twice the
levels of IL-1β than summer PMc. Similar results were observed for TNF-α. IL-1β increased
in a linear fashion in response to both winter and summer PMc. However, IL-1β from winter
and summer PM2.5 increased logarithmically, and leveled out at around 25 pg/mL. This
logarithmic growth was not observed for TNF-α, as all four PM types generated linear
increases in cytokine expression.
The data on the significant differences between PMc and PM2.5 are listed in Table 3. Two-
tailed, student t-tests were used to determine if the two PM size fractions induced
significantly different responses at a single dose. Both summer and winter PMc induced
significantly higher IL-1β levels compared to their PM2.5 counterparts (at 20μg, IL-1β
between summer PMc v. PM2.5 p=0.02, and winter PMc v. PM2.5 p=0.03). TNF-α levels
were only significantly different between PMc and PM2.5 for winter, but not for summer (at
20μg, TNF-α between summer PMc v. PM2.5 p=0.09, and winter PMc v. PM2.5 p=0.0002).
IL-1β levels from winter PMc were triple that of summer PMc. Differences in IL-1β levels
were mostly non-significant when comparing low doses of PM exposure, except between
both summer and winter PM2.5 where there was no significant differences. These results
suggest that PMc is an important mediator in inducing an inflammatory response.
Cellular uptake of ambient PM10
Most of the particles used in these exposures were phagocytosed by the BMdMs, as the
majority of the particles were intracellular (Figure 2). Using BFI microscopy, we determined
that the cells exposed to PM10 had phagocytosed the majority of the particles in solution. In
other images where PMc and PM2.5 burden in PM10 varied, similar uptake was observed
(images not shown). Particle size (both PM2.5 and PMc) did not seem to play a major role in
the uptake of these particles. Small particles and larger sized particulates, such as the fungi,
Torula herbarum (Figure 2), with diameters of approximately 3-4 μm, appear to be equally
phagocytosed. This confirms that both PMc and PM2.5 are being taken up by the BMdMs.
PM endotoxin burden
Endotoxin levels were determined as a function of PM mass (Figure 3). Results show that
overall endotoxin concentrations were highest during the summer months compared to the
winter months for both fractions. As predicted, there was more endotoxin in the winter PMC
compared to the winter PM2.5. Endotoxin concentrations during the summer were
comparable between the two size fractions. These results suggest that endotoxin
concentrations composing ambient PM can vary as a function of PM size and season, and
not primarily found in the coarse fraction (compared to the fine fraction).
Mixture effects
As noted earlier, PM2.5 and PMc used in the mixture exposures were harvested during May
2012. Results from the mixture studies show that varying the combinations of PM2.5 and
PMc in PM10 influence cytokine output, with Figure 4 illustrating the effect of PMc in a
PM10 mixture. All cytokine concentrations (i.e. [IL-1β] and [TNF-α]) varied as a function of
exposure to 20 μg of each PM type (PM10, PM2.5, or PMc). Shown in Figure 4, as PM10
gains a greater proportion of PMc, a synergistic release of IL-1β and TNF-α occurs.
Conversely, as the fraction of PM10 contains more PM2.5 than PMc, antagonistic effects are
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observed. These results support our hypothesis that the PMc fraction is an important
mediator in inducing an inflammatory response with PM10 exposure.
Discussion
Understanding the mass ratio mixtures of ambient PM2.5 and PMc composing PM10 can help
determine additivity of the inflammatory response. As shown in our controlled laboratory
studies, PMc was constantly more bioactive than PM2.5 throughout each side-by-side
exposure in comparing both summer and winter months, and with its increased burden in
PM10. We were successful in showing that there are certainly additive effects from these
different mass ratio exposures. Furthermore, our results suggest that the outcome from
exposure to PM10 can be partly understood as a function of PM2.5 and PMc burden in PM10.
A source apportionment study has yet to be completed for PMc in Missoula, MT. However,
PM2.5 source apportionment modeling has shown that the largest PM2.5 source throughout
the year is wood combustion, contributing an average of 41% to the fine fraction. This
includes residential wood combustion during the winter, slash and prescribed burns from the
surrounding areas during the spring and fall, and smoke from wildfires during the summer
months. Other sources of PM2.5 throughout the year include diesel exhaust (19%),
secondary ammonium nitrate (17%), local industry (20%), and street sand (5%) (Ward and
Smith 2005, Ward and Lange 2010). Though these studies did not focus specifically on
apportioning the sources of PMc, they do provide an idea of the types of exposure conditions
that exist throughout the year in Missoula, MT.
The present study is the first attempt at determining ambient concentrations of PMc in the
state of Montana within the last 15 years. As illustrated in Table 1, ambient concentrations
of PMc were consistently greater than PM2.5 throughout the year, with the exception of the
winter months where the average PMc and PM2.5 concentrations were not significantly
different. It should be noted, however, that harvested particles used in our laboratory studies
were collected on days when the average PMc mass concentrations were about 2 - 10 μg/m3
greater than PM2.5. In addition, particles were harvested during sample days in which there
was higher winter PMc concentrations (22.6±9.2 μg/m3) compared to the winter 2012
average PMc concentrations presented in Table 1 (9.3±7.7 μg/m3). PM2.5 concentrations
(both throughout the winter of 2012 and during the dates of sample collection) were
consistent (9.1±4.9 μg/m3 vs. 12.3±3.0 μg/m3). During the PMc vs. PM2.5 Comparison
studies, particle exposure levels (PM2.5 and PMc) were normalized at 5 μg, 20 μg, and 40
μg/well in the 96-well plates. Therefore, it is unknown how the overall ambient
concentrations during the days of particle harvesting influenced the results of the
comparison studies (if at all). Additional studies within the laboratory across multiple
seasons/years will be able to address this issue.
As evidenced in Figure 3, the differences in endotoxin content on the PM cannot explain the
differences in the resulting IL-1β expression. Something other than endotoxin is potentially
stimulating the production of pro-IL-1β upon exposure to PMc, as the levels of IL-1β do not
seem to be limited with an increase in PMc exposure. In addition, increasing concentrations
of PM2.5 did not induce a linear increase in IL-1β expression (Figure 1). Further studies can
evaluate the levels of pro-IL-1β in cells, via western blot, to determine if a decreased IL-1β
release is due to a lowered level of expression of the pro form of IL-1β or if the
inflammasome is simply not active. A large pool of pro-IL-1β remaining in the cells would
suggest that there is likely a decrease in inflammasome activation, which catalyzes the
maturation of pro-IL-1β to its active IL-1β form (Tschopp 2008).
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Figure 1 supports the hypothesis that ambient PMc is more bioactive than PM2.5. However,
these exposures were done on a side-by-side comparison using controlled laboratory
conditions, and did not take into account that real-world exposures to these two size
fractions occur concomitantly. The mixture exposures take into account possible mixing
conditions of PM2.5 and PMc in PM10. The results of the in vitro mixture exposures showed
that PM2.5 is not as potent an activator of the inflammasome as PMc, even in the presence of
another PM type. In order to stimulate these levels of IL-1β production, the inflammasome
complex must be activated by a receptor (e.g. binding of receptor to PAMP) or lysosomal
stress (e.g. the release of cathepsin-B) (Tschopp 2008, Yazdi et al. 2010). Potentially, there
are components in PMc that are responsible for priming the formation of the inflammasome,
such as endotoxin, an activator of the NF-κB pathway via TLR4, and another component
affecting lysosomal membrane integrity. NF-κB activation is a precursor to transcription
induction of pro-IL-1β (Yazdi et al. 2010, De Nardo and Latz 2011). Activation of the TLR
or priming of the NF-κB pathway has been shown to stimulate the production of pro-IL-1β
and further production of NLRP3 inflammasome precursors (De Nardo and Latz 2011). It is
likely that not only is the inflammasome being formed, but also more pro-IL-1β is being
produced following PMc exposure. Also, reactive oxygen species (ROS) may play a
significant role in inflammation as generation of ROS from particulates has been shown to
exacerbate the inflammatory response (Fubini and Hubbard 2003). Furthermore, exposure to
biogenic substances, such as pollen, largely found in PMc, can increase ROS in the lung
(Boldogh et al. 2005).
Conclusion
In this study, we utilized harvested ambient particles and biological in vitro models to
investigate potential adverse health effects following exposures to different size fractions
found in the Rocky Mountains in North America. The results of these studies conducted
under controlled laboratory conditions suggest that there are properties (chemical, physical,
or biological) of PMc that are responsible for elevated levels of inflammation activity
compared to ambient PM2.5. An important step to further this research would be to
investigate PMc harvested throughout the year. For example, winter PMc contained about
two-thirds the endotoxin burden as compared to summer PMc, yet winter PMc induced more
than twice the levels of IL-1 β than summer PMc. Other methods of in vitro exposure could
also be employed, such as an air-liquid interface model. Also, an alternative method of
collecting particles that does not include the removal of water (via lyophilization) could be
explored to minimize the loss of volatile and semi-volatile compounds. Such methods could
include employing the use of a cyclone or another dry method of harvesting ambient air
particles.
The mixture results presented here suggest that if the percentage of PMc is known, the
relative bioactivity of the ambient PM10 might be predicted. This study supports our
hypothesis that PMc adversely affects macrophage activity with increasing ratios of
PMc:PM2.5 in PM10. It is also important to note that there are currently no National Ambient
Air Quality Standards (NAAQS) for the coarse fraction, though our results suggest that a
new PMc ambient standard should perhaps be considered in addition to the existing daily
and annual PM2.5 NAAQS. Including additional chemical and biogenic characterizations
will facilitate our future source apportionment studies for different PM fractions. Also,
evaluation of reactive oxygen species activity in both PMc and PM2.5 should be considered
in future research. Further seasonal and dose-response relationship studies will aid in
determining real-world mixture effects, as well as provide an understanding of the causal
health effects from exposure to PMc.
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Figure 1.
Levels of cytokine production by mass of PM added per well (containing 100 000 BMdMs).
The left and right graphs are IL-1β and TNF- α levels, respectively, in response to PM and
controls.
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Figure 2.
Cellular uptake of ambient PM10. (A) 40X magnification of BMdMs containing PM10, (B)
Oil immersion 100X magnification showing fungi (spp. Torula herbarum) inside
macrophage.
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Figure 3.
PM Endotoxin content from winter and summer collected ambient particles.
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Figure 4.
Additivity values from different ratios of spring PM2.5 and PMc mixtures. The left and right
graphs are additivity values calculated from IL- 1 β and TNF- α levels, respectively.
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Table 1
Average and ± standard deviation of ambient PM concentrations (μg/m3) in 2012, Missoula, MT.
Winter Spring Summer Fall
Nov-Feb Mar-May June-Aug Sept-Oct
PMC 9.3±7.7 9.6±7.7 13.8±10.7 25.0±30.4
PM2.5 9.1±4.9 5.9±2.6 7.8±6.4 18.1±18.5
PM10 18.4±10.0 15.5±9.8 21.6±12.4 43.1±37.0
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Table 2
Average and ± standard deviation concentrations (μg/m3) during winter and summer days when ambient
particles were harvested.
Winter Spring Summer
Feb, 2012 May, 2012 July, 2011
PMC 22.6±9.2 7.4±1.9 9.7±4.4
PM2.5 12.3±3.0 5.3±1.3 7.4±2.1
PM10 34.9±8.5 12.7±3.2 17.1±6.5
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Table 3
P-values comparing cytokine production of IL−1β or TNF-α between two PM exposure types at 5,20, or 40
μg.
Winter PM2.5 Winter PMc Summer PM2.5 Summer PMc
Winter PM2.5 -------------------------- *, 0.03, 0.01 *, 0.27, 0.16 *, 0.001, 0.003
Winter PMc 0.005, 0.0002, 0.0007 -------------------------- 0.11, 0.04, 0.01 0.16, 0.06, 0.02
Summer PM 2.5 0.009, 0.002, 0.17 0.008, 0.001, 0.001 -------------------------- 0.10, 0.02, 0.01
Summer PMc 0.008, 0.008, 0.06 0.01, 0.01, 0.02 0.06, 0.09, 0.29 --------------------------
Each of the grouped (three) reported p-values from left to right are from 5, 20, and 40 μg exposures, respectively. Italicized = TNF-α, normal type
= IL-1β,
*
= cytokines not detected, cannot compare. Null hypothesis = Cytokines levels are the same between exposure treatments.
